|
|
Umestan Fretagspark
Ume�, SE-903 47 Sweden
phone:090-13 66 50
fax:090-71 80-95
|
|
| Symbol |
INPH |
| Exchange |
STO |
| Founded |
0 |
| Employees |
|
|
|
| www.innate.se
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Scentific progress in innate immunology and microbiology. |
|
| Management |
| Ingemar Kihlstr�m, Chairman of the Board; Claes-G�ran Fridh,MD, founder of Aff�rsstrategerna AB; Staffan Normark, MD., Professor; Sune Rosell, MD., CEO; Kumud Sampath MA, MBA., International Vice President |
| |
|
|
|
|
|
|
| |
|
|
|
|
| Keywords |
| innate, immunology, microbiology, target, anti-infectives, proteins, pathogenic, bacteria, virulence, nuclear, fruit, fly, AllergyImmunology |
|
|
|
|
|
|
| Description |
|
Innate Pharmaceuticals is focused on drug discovery, and is positioned to commercialize scentific progress in innate immunology and microbiology. |
|
| Technology / Differentiation |
| InnateVirulens is a technology platform containing drug targets for new types of anti-infectives. InnateTypIII is a platform to screen for anti-infectives which inhibit the type III secretion system. InnateToll is a platform for screening for inhibitors of inflammatory processes based on the fruit fly Drosophila. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members